The study of Naruszewicz et al. has shown that trans fatty acids cause a significant increase in the secretion of metalloproteinase -9, reactive oxygen species, interleukin -6,
and tumor necrosis factor. It was concluded that trans fatty acids may contribute to the destruction of endothelial integ-rity and to increased risk of plaque rupture [69].
References
Ascherio A., Willett W.C.
1. : Health effects of trans fatty acids. Am J Clin Nutr. 1997, 66, 1006S–1010S.
Ratnayake W.M., L’Abbe M.R., Mozaffarian D.
2. : Nationwide product
reformulations to reduce trans fatty acids in Canada: when trans fat goes out, what goes in? Eur J Clin Nutr. 2009, 63, 808–811.
Albers M.J., Harnack L.J., Steffen L.M., Jacobs D.R.
3. : 2006
market-place survey of trans -fatty acid content of margarines and butters, cookies and snack cakes, and savory snacks. J Am Diet Assoc. 2008, 108, 367–370.
Aro A., Antoine J.M., Pizzoferrato L., Reykdal O., van Poppel G.
4. : Trans
fatty acids in dairy and meat products from 14 European countries: The TRANSFAIR study. J Food Comp Anal. 1998, 2, 137–147.
Craig -Schmidt M.C.
5. : World -wide consumption of trans fatty acids.
Atheroscler Suppl. 2006, 7, 1–4.
Mozaffarian D., Abdollahi M., Campos H., Houshiarrad A., Willett 6.
W.C.: Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr. 2007, 61, 1004–1010.
Holmqvist O.
7. : Trans fatty acids in hardened vegetable oils. Athero-sclerosis. 1996, 120, 245–247.
King J.M., White P.J.
8. : Impact of processing on formation of trans fatty acids. Adv Exp Med Biol. 1999, 459, 51–65.
Romo G.A., Erdman E.A., Teter B.B., Sampugnat J., Casper D.P.
9. : Milk
composition and apparent digestibilities of dietary fatty acids in lac-tating dairy cows abomasally infused with Cis or Trans fatty acids. J Dairy Sci. 2000, 83, 2609–2619.
Molkentin J.
10. : Bioactive lipids naturally occurring in bovine milk. Nah-rung. 1999, 43, 185–189.
Mojska A.
11. : Influence of trans fatty acids on infant and fetus develop-ment. Acta Microbiol Pol. 2003, 52, 67–74.
Willett W.C., Ascherio A.
12. : Trans fatty acids: Are the effects only mar-ginal. Am J Public Health. 1994, 84, 722–724.
Marckamann P.
13. : Trans fatty acids and dieting. Lancet. 1993, 341, 1094.
Jones D.
14. : Trans fatty acids and dieting. Lancet. 1993, 341, 1093.
Heffernan G.A.
15. : The fatty acids composition of human adipose tissue.
Clin Sci. 1963, 25, 423–429.
Garland M., Sacks F.M., Colditz G.A., Rimm E.B., Sampson L.A., Wil-16. let W.C. et al.: The relation between dietary intake and adipose tissue composition of selected fatty acids in women. Am J Clin Nutr. 1998, 67, 25–30.
Kinsella J.E., Bruckne G.R., Mai J., Shimp J.
17. : Metabolism of trans fatty
acids with emphasis on the effects of trans, trans -octadecadienoate on lipid composition, essential fatty acid, and prostaglandins: an over-view. Am J Clin Nutr. 1981, 34, 2307–2318.
Roach C., Feller S.E., Ward J.A., Shaikh S.R., Zerouga M., Stillwell W.
18. :
Comparison of cis and trans fatty acid containing phosphatidylcholines on membrane properties. Biochemistry. 2004, 43, 6344–6351.
Thomas L.H., Winter J.A., Scott R.G.
19. : Concentration of 18:1 and 16:1
transunsaturated fatty acids in the adipose body tissue of decedents dying of ischaemic heart disease compared with controls: analysis by gas liquid chromatography. J Epidemiol Community Health. 1983, 37, 16–21.
Roberts T.L., Wood D.A., Riemesma R.A., Gallagher P.J., Lampe F.C.
20. :
Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet. 1995, 345, 278–282.
Hudgins L.C., Hirsch J., Emken E.A.
21. : Correlation of isomeric fatty acids
in human adipose tissue with clinical risk factors for cardiovascular disease. Am J Clin Nutr. 1990, 53, 474–482.
TRANS FATTy ACIDS AND THEIR ROLE IN INFLAMMATION AND CARDIOVASCULAR DISEASE 37
Clifton P.M., Keogh J.B., Noakes M.
22. : Trans fatty acids in adipose
tis-sue and the food supply are associated with myocardial infarction. J Nutr. 2004, 134, 874–879.
Sun Q.
23. : Comparison between plasma and erythrocyte fatty acid con-tent as biomarkers of fatty acid intake in US women. Am J Clin Nutr.
2007, 86, 74–81.
Sun Q., Ma J., Campos H., Hankinson S.E., Manson J.E., Stampfer 24.
M.J. et al.: A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation. 2007, 10, 1858–1865.
Murray R.D., Granner D.K., Mayes P.A., Rodwell V.W.
25. : Biochemistry.
24th edition. Appleton & Lange, New york 1996, 794–813.
Mahfouz M.
26. : Effect of dietary trans fatty acids on the delta 5, delta 6 and delta 9 desaturases of rat liver microsomes in vivo. Acta Biol Med Ger. 1981, 40, 1699–1705.
De Schrijver R., Privett O.S.
27. : Interrelationship between dietary trans Fat-ty acids and the 6 - and 9 -desaturases in the rat. Lipids. 1982, 17, 27–34.
Kummerow F.A., Zhou Q., Mahfouz M.M., Smiricky M.R., Grieshop 28. C.M., Schaeffer D.J.: Trans fatty acids in hydrogenated fat inhibited the synthesis of the polyunsaturated fatty acids in the phospholipid of arterial cells. Life Sci. 2004, 16, 2707–2723.
Koga T., Nonaka M., Gu J.Y., Sugano M.
29. : Linoleic and alpha -linolenic
acids differently modify the effects of elaidic acid on polyunsaturated fatty acid metabolism and some immune indices in rats. Br J Nutr.
1997, 77, 645–656.
Mensink R.P.
30. : Essential and trans -fatty acids. Curr Opin Lipidol. 1996, 7, 1–2.
Klewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisley G.B., Kobles 31.
C.S. et al.: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator -activated receptors α and γ. Proc Natl Acad Sci USA. 1997, 94, 4318–4323.
Tontonoz P., Nagy L., Alvarez J.G.A., Thomazy V.A., Evans R.M.
32. : PPAR
γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1988, 93, 241–252.
Lagrost L.
33. : Differential effect of cis and trans fatty acid isomers, oleic and elaidic acids, on the cholesteryl ester transfer protein activity.
Biochim Biophys Acta. 1992, 1124, 159–161.
Moore C.E., Alfin -Slater R.B., Aftergood L.
34. : Effect of trans fatty acids
on serum lecithin: cholesterol acyltransferase in rats. J Nutr. 1980, 110, 2284–2290.
Matthan N.R., Welty F.K., Barrett P.H., Harausz C., Dolnikowski G.G., 35.
Parks J.S. et al.: Dietary hydrogenated fat increases high -density li-poprotein apoA -I catabolism and decreases low -density lili-poprotein apoB -100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004, 24, 1092–1097.
Mensink R.P., Katan M.B.
36. : Effect of dietary trans fatty acids in -density and low -density lipoprotein cholesterol levels in healthy
sub-jects. N Engl J Med. 1990, 323, 439–445.
Zock P.L., Katan M.B.
37. : Butter, margarine and serum lipoproteins.
Atherosclerosis. 1997, 131, 7–16.
Katan M.B.
38. : Trans fatty acids and plasma lipoproteins. Nutr Rev. 2000, 58, 188–191.
Sundram K., Karupaiah T., Hayes K.C.
39. : Stearic acid -rich
interesteri-fied fat and trans -rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans. Nutr Metab. 2007, 15, 4–11.
Judd J.T., Baer D.J., Clevidence B.A., Muesing R.A., Chen S.C., West-40.
strate J.A. et al.: Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in nor-molipemic adults fed controlled diets. Am J Clin Nutr. 1998, 68, 768–777.
Matthan N.R., Ausman L.M., Lichtenstein A.H., Jones P.J.
41. :
Hydro-genated fat consumption affects cholesterol synthesis in moderately hypercholesterolemic women. J Lipid Res. 2000, 41, 834–839.
Chardigny J.M., Destaillats F., Malpuech -Brugère C., Moulin J., 42. Bauman D.E., Lock A.L. et al.: Do trans fatty acids from
industri-ally produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr. 2008, 87, 558–566.
Motard -Bélanger A., Charest A., Grenier G., Paquin P., Chouinard Y., 43.
Lemieux S. et al.: Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr. 2008, 87, 593–599.
Tricon S., Burdge G.C., Jones E.L., Russell J.J., El -Khazen S., Moretti 44.
E. et al.: Effects of dairy products naturally enriched with cis -9, trans -11 conjugated linoleic acid on the blood lipid profile in healthy -aged men. Am J Clin Nutr. 2006, 83, 744–753.
Clevidence B.A., Judd J.T., Schaefer E.J., Jenner J.L., Lichtenstein A.H., 45.
Muesing R.A. et al.: Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis -, or trans -monounsaturated fatty acids. Arterioscler Thromb Vasc Biol. 1997, 17, 1657–1661.
Mensik R.P., Zock P.L., Katan M.B., Hornsta G.
46. : Effect of dietary cis
and trans fatty acids on serum lipoprotein (a) in primary hypertrig-lyceridemia. Atherosclerosis. 1991, 90, 95–97.
Almendingen K., Jordal O., Kierulf P., Sandstad B., Pedersen J.L.
47. :
Ef-fects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp(a) in men. J Lipid Res.
1995, 36, 1370–1387.
Nestel P., Noakes M., Belling B., McArthur R., Clifton P., Janus E. et al.
48. :
Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res. 1992, 33, 1029–1036.
Brown S.A., Morrisett J., Patsch J.R., Reeves R., Gotto A.M., Patsch 49.
W.: Influence of short term dietary cholesterol and fat on human plasma Lp(a) and LDL levels. J Lipid Res. 1991, 32, 1281–1289.
Mozaffarian R., Rimm E.B., King I.B., Lawler R.L., McDonald G.B., 50.
Levy W.C.: Trans fatty acids and systemic inflammation in heart failure.
Am J Clin Nutr. 2004, 80, 1521–1525.
Basu A., Devaraj S., Jilal I.
51. : Dietary factors that promote or retard
inflammation. Arterioscler Thromb Vasc Biol. 2006, 26, 995–1001.
Lennie T.A., Chung M.L., Habash D.L., Moser D.K.
52. : Dietary fat intake
and proinflammatory cytokine levels in patients with heart failure. J Card Fail. 2005, 11, 613–618.
Lopez -Garcia E., Schulze M.B., Meigs J.B., Manson J.E., Rifai N., Stamp-53.
fer M.J. et al.: Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr. 2005, 135, 562–566.
Baer D.J., Judd J.T., Clevidence B.A., Tracy R.P.
54. : Dietary fatty acids
af-fect plasma markers of inflammation in healthy men fed controlled diets:
a randomized crossover study. Am J Clin Nutr. 2004, 79, 969–973.
Balazy M.
55. : Trans -arachidonic acids: new mediators of inflammation.
J Physiol Pharmacol. 2000, 51, 597–607.
Cardiovascular diseases. World Health Organization, Feb 2007. http://
56.
www.who.int/mediacentre/factsheets/fs317/en/index.html (28 Jan 2009).
Lopes C., Aro A., Azevedo A., Ramos E., Barros H.
57. : Intake and adipose
tissue composition of fatty acids and risk of myocardial infarction in a male Portuguese community sample. J Am Diet Assoc. 2007, 107, 276–286.
Shrapnel W.S., Cavert G.D., Nestel P.J., Truswell A.S.
58. : Diet and
coro-nary heart disease. The National Heart Foundation of Australia. Med J Aust. 1992, 4, S9–16.
Ghahremanpour F., Firoozrai M., Darabi M., Zavarei A., Mohebbi A.
59. :
Adipose tissue trans fatty acids and risk of coronary artery disease:
a case -control study. Ann Nutr Metab. 2008, 52, 24–28.
Stachowska E., Dołęgowska B., Chlubek D., Wesołowska T., Ciecha-60. nowski K., Gutowski P. et al.: Dietary trans fatty acids and composition
of human atheromatous plaques. Eur J Nutr. 2004, 43, 318–333.
Mosley E.E., Wright A.L., McGurie M.K., McGurie M.A.
61. : Trans fatty
acids in milk produced by women in the United States. Am J Clin Nutr. 2005, 82, 1292–1297.
Pietinen P., Ascheiro A., Korhonien P., Hartman A.M., Willet W.C., 62.
Albanes C. et al.: Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: The Alpha -Tocopherol, Beta -Carotene Cancer Prevention Study. Am J Epidemiol. 1997, 145, 876–887.
Oh K., Hu F.B., Manson J.E., Stampfer M.J., Willett W.C.
63. : Dietary
fat intake and risk of coronary heart disease in women: 20 years of
38 EWA STACHOWSKA, DOMINIKA JAMIOł, DARIUSZ CHLUBEK follow -up of the Nurses’ Health Study. Am J Epidemiol. 2005, 161,
672–679.
Xu J., Eilat -Adar S., Loria C., Coldbourt U., Howard B.V., Fabsitz 64.
R.R. et al.: Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr. 2006, 84, 894–902.
Pedersen J.I., Ringstad J., Almendingen K., Haugen T.S., Stensvold I., 65.
Thelle D.S.: Adipose tissue fatty acids and risk of myocardial infarc-tion – a case -control study. Eur J Clin Nutr. 2000, 54, 618–625.
Lemaitre R.N., King I.B., Mozaffarian D., Sotoodehnia N., Rea T.D., 66.
Kuller L.H. et al.: Plasma phospholipid trans fatty acids and fatal isch-emic heart disease in older adults. Circulation. 2006, 114, 209–215.
Merchant A.T., Kelemen L.E., de Koning L., Lonn E., Vuksan V., Ja-67.
cobs R. et al.: SHARE and SHARE -AP investigators: Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis.
Am J Clin Nutr. 2008, 87, 168–174.
Harvey K.A., Arnold T., Rasool T., Antalis C., Miller S.J., Siddiqui R.A.
68. :
Trans -fatty acids induce pro -inflammatory responses and endothelial cell dysfunction. Br J Nutr. 2008, 99, 723–731.
Naruszewicz M., Daniewski M., Nowicka G., Kozłowska -Wojciechowska 69. M.: Trans -unsaturated fatty acids and acrylamide in food as potential atherosclerosis progression factors. Based on own studies. Acta Mi-crobiol Pol. 2003, 52, 75–81.
A N N A L E S A C A D E M I A E M E D I C A E S T E T I N E N S I S
R O C Z N I K I P O M O R S K I E J A K A D E M I I M E D Y C Z N E J W S Z C Z E C I N I E 2010, 56, 3, 39–49
EWA LEWANDOWSKA, BOżENA BIRKENfELD, BARTOSZ KACZMAREK, PIOTR ZORGA, MARIA LISTEWNIK